Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

World Incretin-Based Drugs Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

Research and Markets
Posted on: 26 Jul 17

The "World Incretin-Based Drugs Market - Opportunities and Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs.


  • Comprehensive analysis of factors that drive and restrict the growth of the global incretin-based drugs market is provided
  • The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • An in-depth analysis of key segments of the market demonstrates the types of drugs and formulations that are currently being used along with the variants that would gain prominence in future
  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
  • Region-wise incretin-based drugs market conditions are comprehensively analyzed in the report


Global Incretin Based Drugs Market - By Drug Type

  • Glucagon-like peptide-1 receptor (GLP-1) agonists
  • Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Global Incretin Based Drugs Market - By Formulation

  • Oral Drugs
  • Injectable Drugs

Global Incretin Based Drugs Market - By Geography

  • North America
  • Europe
  • Asia-Pacific

For more information about this report visit

View source version on

Business Wire

Last updated on: 26/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.